Download presentation
Presentation is loading. Please wait.
1
Formulating for EfficacyTM
Copyright © 2014 ACT Solutions Corp. All rights reserved.
2
Why Formulate for Efficacy?
Actives are expensive Claims substantiation is expensive Advertising is expensive Litigation is expensive Getting new customers is expensive Developing new products is expensive
3
Standard formulation design process
Clinical testing Stable base Concentration Model activity Intrinsic activity
4
How to increase skin delivery?
K = Partition coefficient (of active between formulation and skin) The math bit… D = Diffusion coefficient (of active into skin) L= Path length (of active through skin) Ficks’ 1st Law (~rate of active penetrating into skin): J is from Ficks first law, for penetrant going through membrane. Two key things we can affect: 1) Initial concentration in formulation – flux is increased when this is increased 2) Partition coefficient K: in order to get active into skin, it must penetrate from formulation into stratum corneum, controlled by K, ratio of maximum solubilities. Therefore, the quantity of molecules penetrating into the stratum corneum can be increased by increasing the solubility of the penetrating molecule in the stratum corneum or by reducing its solubility in the formulation. Rate of active penetrating into skin can be increased by maximizing the initial amount in the formulation
5
Categories of actives Insoluble Oil soluble/low polarity
Sparingly water soluble Freely water soluble
6
Hansen solubility parameters
Solvency predictions Dispersion forces van der Waals forces Polar forces Dipolar intermolecular forces Hydrogen bonding forces Electromagnetic attractive interactions
7
Assessing other challenges to delivery posed by actives
Size MolV (Molar Volume) Difference in polarity with Stratum Corneum ASG (Active Skin Gap)
8
Franz Diffusion Cell Data
3.5 fold increase 5 10 15 Formulation not optimised for delivery Delivery optimised formulation Dioic Acid Delivery ( μ g/cm 2 ) Tapes Stratum Corneum Receptor fluid
9
Formulating for Efficacy™ Approach
Intrinsic activity Model activity Assess properties Evaluate challenges Design active phase for solubility and driving force
10
Dynamics of product on the skin
Application Evaporation Permeation
11
Impact of the Emulsifier
Stability (OK, that’s obvious) Aesthetics (yes, but how much?) Delivery (where does it fit with such approaches as Formulating for Efficacy™ ?)
12
Wiechers study shows that emulsifier selection controls:
74% of overall aesthetic quality of an emulsion Nearly 100% of Appearance, Pick-up, and Rub-out characteristics MESSAGE: Change emulsifier to change aesthetics Use emollient variation to adjust After-feel
13
Emulsion Stabilization Mechanisms
Steric Charge Pickering Polymer Liquid crystalline
14
Adaptive Approach to Aesthetic Design
Emulsifier Appearance, Pick-up, Rub-out Test with target audience Emollient Adjusting After-feel
15
Driving Development Water, Polar Carriers and Humectants, Actives, Polymers Emulsifiers Emollients, Actives, Waxes
16
Enlightened Formulation Wheel
Actives Emulsifiers Polar carriers, humectants Emollients Fragrance Preservative Polymers and waxes
17
Further formulation design
Design emulsion for aesthetics Design emulsion for delivery Test with target audience Clinical trials Success !!
18
Contact information Mark Chandler President, ACT Solutions Corp Research Instructor, Univ. of Toledo Office: Mobile: 550 S. College Ave., Suite 110 Newark, DE
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.